CIK 0001410098 · Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Stewart Robert A Director | Purchase | +10,000 | $4.37 | $44K | 11,000 |
| 2023-05-17 | Todisco Joseph Chief Executive Officer | Purchase | +5,000 | $4.58 | $23K | 209,726 |
| 2023-05-17 | Costa Paulo F Director | Grant or award | +10,000 | $4.65 | $47K | 10,000 |
| 2023-05-17 | DUNTON ALAN W Director | Grant or award | +3,000 | $4.33 | $13K | 9,250 |
| 2023-05-17 | Stewart Robert A Director | Grant or award | +10,000 | $4.37 | $44K | 11,000 |
| 2023-05-17 | Todisco Joseph Chief Executive Officer | Grant or award | +5,000 | $4.58 | $23K | 209,726 |
| 2023-05-10 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes 10b5-1 | −37,443 | $5.30 | $198K | 204,726 |
| 2023-04-13 | Stewart Robert A Director | Grant or award · Stock Option (Right to Buy Common Stock) | +25,000 | 25,000 | ||
| 2023-04-13 | Stewart Robert A Director | Grant or award · Stock Option (Right to Buy Common Stock) | +14,200 | 14,200 | ||
| 2023-01-14 | Mistry Erin Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +75,000 | 75,000 | ||
| 2023-01-14 | Todisco Joseph Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +400,000 | 400,000 | ||
| 2023-01-14 | Mounts Phoebe General Counsel | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | 125,000 | ||
| 2023-01-14 | Lefkowitz Steven W Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2023-01-14 | Dillione Janet Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2023-01-14 | Kaplan Myron Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2023-01-14 | Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +125,000 | 125,000 |
Page 9 of 9 · 176 trades